Qiagen s Q4 Revenues Jump 29 Percent, Stock Falls | GenomeWeb

NEW YORK, Feb 20 -- Qiagen's fourth quarter revenues rose 29 percent to $55.8 million from $42.3 million for the fourth quarter of 1999, the company reported Tuesday.

The Dutch company, profitable since 1990, also reported profits of $6.6 million or 5 cents per share for the quarter, up from four cents per share or $6 million for the previous fourth quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.